JP2016518114A - オリゴ糖組成物、糖タンパク質および原核生物においてそれらを産生する方法 - Google Patents

オリゴ糖組成物、糖タンパク質および原核生物においてそれらを産生する方法 Download PDF

Info

Publication number
JP2016518114A
JP2016518114A JP2016502303A JP2016502303A JP2016518114A JP 2016518114 A JP2016518114 A JP 2016518114A JP 2016502303 A JP2016502303 A JP 2016502303A JP 2016502303 A JP2016502303 A JP 2016502303A JP 2016518114 A JP2016518114 A JP 2016518114A
Authority
JP
Japan
Prior art keywords
glcnac
host cell
man
protein
mannose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016502303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518114A5 (https=
Inventor
フィッシャー，アダム，シー．
メリット，ジュディス，エイチ．
ハミルトン，ブライアン，エス．
ヴァルデラマ−リンコ，フアン，ディー．
デリサ，マシュウ，ピー．
Original Assignee
グリコビア，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グリコビア，インコーポレイテッド filed Critical グリコビア，インコーポレイテッド
Publication of JP2016518114A publication Critical patent/JP2016518114A/ja
Publication of JP2016518114A5 publication Critical patent/JP2016518114A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2016502303A 2013-03-14 2014-03-14 オリゴ糖組成物、糖タンパク質および原核生物においてそれらを産生する方法 Pending JP2016518114A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785586P 2013-03-14 2013-03-14
US61/785,586 2013-03-14
PCT/US2014/026990 WO2014152137A2 (en) 2013-03-14 2014-03-14 Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes

Publications (2)

Publication Number Publication Date
JP2016518114A true JP2016518114A (ja) 2016-06-23
JP2016518114A5 JP2016518114A5 (https=) 2017-04-20

Family

ID=51528818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502303A Pending JP2016518114A (ja) 2013-03-14 2014-03-14 オリゴ糖組成物、糖タンパク質および原核生物においてそれらを産生する方法

Country Status (8)

Country Link
US (2) US20140273163A1 (https=)
EP (1) EP2971030B8 (https=)
JP (1) JP2016518114A (https=)
KR (1) KR20160021075A (https=)
CN (1) CN105378096A (https=)
CA (1) CA2906671A1 (https=)
SG (2) SG11201508347YA (https=)
WO (1) WO2014152137A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104388372B (zh) * 2014-12-04 2017-07-21 江南大学 一种产软骨素的重组枯草芽孢杆菌及其应用
JP6762027B2 (ja) * 2016-08-25 2020-09-30 株式会社雅嘉貿易 シアロオリゴ糖の製造方法とその利用
BR112019015425A2 (pt) 2017-01-27 2020-05-26 University Of Florida Research Foundation, Incorporated Uma vacina de segurança alimentar para controlar salmonella enterica e reduzir campylobacter em aves domésticas
EP3844271A4 (en) 2018-08-29 2022-06-01 Council of Scientific and Industrial Research Recombinant microbial system for directed evolution of glycocins and a method of preparation thereof
CN110294810B (zh) * 2019-06-26 2021-05-04 中国疾病预防控制中心传染病预防控制所 一种含有人IgG1Fc和甘露聚糖结合凝集素C端的重组蛋白
CN111534495B (zh) * 2020-05-14 2022-06-17 江南大学 一种提高重组n-乙酰葡糖胺转移酶ii可溶性表达的方法
CA3188909A1 (en) 2020-08-10 2022-02-17 Sofie AESAERT Production of an oligosaccharide mixture by a cell
ES2966260T3 (es) 2020-08-10 2024-04-19 Inbiose Nv Producción de una mezcla de oligosacáridos neutros no fucosilados por una célula
WO2022162704A1 (en) * 2021-02-01 2022-08-04 Dr. Reddy's Laboratories Limited Compositions comprising fusion protein and analytical attributes thereof
WO2023122641A1 (en) * 2021-12-22 2023-06-29 Zymergen Inc. Compositions and methods for producing acetic acid and polysaccharides
EP4265730A1 (en) * 2022-04-19 2023-10-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Cell-free enzymatic method for preparation of n-glycans
JP2025513499A (ja) 2022-04-19 2025-04-24 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー Ｎ－グリカンの調製のための無細胞酵素法
WO2024218743A1 (en) * 2023-04-21 2024-10-24 Glycoera Ag Multi-functional molecules comprising glycans and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500018A (ja) * 2001-04-02 2005-01-06 アイデック ファーマスーティカルズ コーポレイション ＧｎＴＩＩＩと同時発現する組換え抗体

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
DE19754622A1 (de) * 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
CA2351022A1 (en) * 1998-11-18 2000-05-25 Neose Technologies, Inc. Low cost manufacture of oligosaccharides
US8697394B2 (en) * 2000-06-28 2014-04-15 Glycofi, Inc. Production of modified glycoproteins having multiple antennary structures
US7449308B2 (en) * 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7795210B2 (en) * 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
AU2003234445B2 (en) * 2002-05-02 2009-11-26 Vanderbilt University Mammalian genes involved in viral infection and tumor suppression
CA2591992A1 (en) * 2004-12-22 2006-06-29 The Salk Institute For Biological Studies Compositions and methods for producing recombinant proteins
CA2600391A1 (en) * 2005-03-07 2006-09-14 Plant Research International B.V. Glycoengineering in mushrooms
US20100143969A1 (en) * 2005-03-24 2010-06-10 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
WO2006112025A1 (ja) * 2005-04-15 2006-10-26 Japan Tobacco Inc. 新規なβ－ガラクトシド－α２，３－シアル酸転移酵素、それをコードする遺伝子およびその製造方法
US8198045B2 (en) * 2006-04-19 2012-06-12 Biogenerix Ag Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms
CN107119095B (zh) * 2008-01-03 2022-07-05 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
US9927440B2 (en) * 2009-11-25 2018-03-27 Duke University Protein engineering
US9051593B2 (en) * 2009-12-21 2015-06-09 Trustees Of Dartmouth College Recombinant prokaryotes and use thereof for production of O-glycosylated proteins
WO2012050175A1 (ja) * 2010-10-15 2012-04-19 日本ケミカルリサーチ株式会社 糖鎖の非還元末端がマンノース残基である糖蛋白質の製造方法
EP2643456B1 (en) * 2010-11-24 2016-05-11 Novartis International Pharmaceutical Ltd. Fusion enzymes having n-acetylglucosaminyltransferase activity
KR101906623B1 (ko) * 2011-03-04 2018-10-10 가부시키가이샤 도우사 고가쿠 겐큐쇼 시알산 함유 당쇄의 제조방법
EP2741772A1 (en) * 2011-08-08 2014-06-18 ETH Zurich Pasteurellaceae vaccines
WO2013067523A1 (en) * 2011-11-04 2013-05-10 Cornell University A prokaryote-based cell-free system for the synthesis of glycoproteins
RU2645252C2 (ru) * 2012-01-05 2018-02-19 Глюкос Финланд Ой Клетка нитчатых грибов с дефицитом протеаз и способы ее применения
WO2014048439A1 (en) * 2012-09-25 2014-04-03 Glycom A/S Glycoconjugate synthesis
ES2905107T3 (es) * 2012-10-12 2022-04-07 Glaxosmithkline Biologicals Sa Procedimientos de modificación de células hospedadoras

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500018A (ja) * 2001-04-02 2005-01-06 アイデック ファーマスーティカルズ コーポレイション ＧｎＴＩＩＩと同時発現する組換え抗体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J.BIOL.CHEM.(2013), VOL.288, NO.10, P.6912-6920(PUBLISHED ONLINE JANUARY 17, 2013), JPN6018005076, ISSN: 0003741271 *
NAT.CHEM.BIOL.,VOL.8, NO.5, P.434-436, JPN6018005075, ISSN: 0003741270 *

Also Published As

Publication number Publication date
US20160177355A1 (en) 2016-06-23
CA2906671A1 (en) 2014-09-25
SG11201508347YA (en) 2015-11-27
EP2971030A2 (en) 2016-01-20
WO2014152137A8 (en) 2015-12-30
WO2014152137A3 (en) 2014-12-11
EP2971030B1 (en) 2018-10-17
US20140273163A1 (en) 2014-09-18
WO2014152137A2 (en) 2014-09-25
SG10201707565WA (en) 2017-10-30
EP2971030A4 (en) 2017-03-15
KR20160021075A (ko) 2016-02-24
CN105378096A (zh) 2016-03-02
EP2971030B8 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
EP2971030B1 (en) Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
JP7437162B2 (ja) 改変されかつ完全に機能カスタマイズされた糖タンパク質
JP5667880B2 (ja) 原核生物におけるグリコシル化されたタンパク質の発現方法
CN105392883A (zh) 聚唾液酸、血型抗原以及糖蛋白表达
Zhang et al. CHO glycosylation mutants as potential host cells to produce therapeutic proteins with enhanced efficacy
WO2019234021A1 (en) Glycoengineered monoclonal antibody
CN108779443A (zh) 产生糖基化蛋白的方法
Khan et al. Strategies for humanizing glycosylation pathways and producing recombinant glycoproteins in microbial expression systems
US12241108B2 (en) Genetically engineered eukaryotic cells producing LacNAc-glycoproteins
Castilho et al. Production of Functionally Active Recombinant Proteins in Plants: Manipulating N‐and O‐glycosylation
Pranomphon et al. Metabolic and Process Engineering to Control Glycan Structures for Biopharmaceuticals Produced in Cultured Mammalian Cells
US12516361B2 (en) Genetically engineered eukaryotic cells producing sialylated glycoproteins
Li et al. Glycoproteins: Chemical features and biological roles
US20220112535A1 (en) Production of protein with humanized n-glycosylation in insect cells
Wildt et al. An alternative approach: Humanization of N-glycosylation pathways in yeast

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20160122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170314

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170314

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20170602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180718

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181204